BioAntibody Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $14.4M

  • Investors
  • 5

BioAntibody General Information

Description

Developer of core raw materials designed for in vitro diagnostics (IVD) and biopharmaceuticals. The company's materials are based on original high-efficiency targeted hybridoma cell fusion technology and supporting stable cell growth factors and high-through-put screening that cover cardiovascular, cerebrovascular, inflammation, infectious diseases, tumors, hormones and other categories, enabling customers to attain higher quality raw materials for better disease detection and therapy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 903/905, Building C6
  • 9 Weidi Road
  • Nanjing, Jiangsu
  • China
+86 025
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Room 903/905, Building C6
  • 9 Weidi Road
  • Nanjing, Jiangsu
  • China
+86 025

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioAntibody Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 11-Jan-2023 $14.4M Completed Generating Revenue
To view BioAntibody’s complete valuation and funding history, request access »

BioAntibody Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Beijing Fangsheng Investment Management Center Growth/Expansion Minority
Bondshine Capital Venture Capital Minority
Guoqian Venture Capital Venture Capital Minority
Nanjing Xingong Emerging Industry Investment Management Growth/Expansion Minority
Phoenix Tree Capital Investment Bank Minority
To view BioAntibody’s complete investors history, request access »

BioAntibody FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process